drugset / Trial / NCT02188615

Study of Neo-adjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Squamous Cell Esophageal Cancer

NCT02188615 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The primary objective is to compare neo-adjuvant chemoradiotherapy followed by Mckeown Minimally Invasive Esophagectomy (MIE) Versus Mckeown MIE, pure radical chemoradiotherapy in terms of the overall survival time (OS) in patients with Stage IIB or III squamous cell esophageal carcinoma.

Timeline

Start
2011-06
Primary completion
2015-06
Completion
2019-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cisplatin Other / unclassified — —